End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.40 CNY | +1.64% | +1.89% | +26.66% |
Dec. 06 | Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials | MT |
Dec. 03 | Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops | MT |
Evolution of the Average Target: Shanghai Shyndec Pharmaceutical Co., Ltd.
Evolution of the Target Price: Shanghai Shyndec Pharmaceutical Co., Ltd.
Changes in Analyst Recommendations: Shanghai Shyndec Pharmaceutical Co., Ltd.
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
- | - | - | +60.00% | |||
+27.03% | ||||||
+23.15% | ||||||
+27.28% | ||||||
+12.33% | ||||||
+19.42% | ||||||
+5.92% | ||||||
+6.83% | ||||||
Average | +22.75% | |||||
Weighted average by Cap. | +25.07% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600420 Stock
- Consensus Shanghai Shyndec Pharmaceutical Co., Ltd.